Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00835757 · ClinicalTrials.gov registry record
Diffusion Tensor Imaging of Sural Nerves in Diabetic Peripheral Neuropathy
A clinical trial of Diabetic Peripheral Neuropathy, sponsored by University of Michigan.
- Completed
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT00835757 is a study of Diabetic Peripheral Neuropathy that has completed, run by University of Michigan. The registered enrollment target is 50 participants, below the 126-participant average among 17 other Diabetic Peripheral Neuropathy trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00835757, a study of Diabetic Peripheral Neuropathy, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to validate magnetic resonance imaging and diffusion tensor imaging (MRI/ DTI) analysis as a non-invasive method for the assessment of myelinated nerve fibers loss in diabetic peripheral neuropathy.
Conditions Studied
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2008-09 |
| Est. Completion | 2012-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00835757
The ClinicalTrials.gov registry entry for NCT00835757 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 126-participant average among 17 other Diabetic Peripheral Neuropathy trials with a reported enrollment target (60% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetic Peripheral Neuropathy appearing as the primary indexed condition, and to 0 interventions.
NCT00835757 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT00835757 about?
NCT00835757 is a clinical study titled "Diffusion Tensor Imaging of Sural Nerves in Diabetic Peripheral Neuropathy". This study aims to validate magnetic resonance imaging and diffusion tensor imaging (MRI/ DTI) analysis as a non-invasive method for the assessment of myelinated nerve fibers loss in diabetic peripheral neuropathy.
What is the current status of trial NCT00835757?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2008-09. Estimated completion is 2012-12.
What conditions does trial NCT00835757 study?
This clinical trial studies the following conditions: Diabetic Peripheral Neuropathy.
Who is sponsoring clinical trial NCT00835757?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00835757 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Peripheral Neuropathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Walking Function in Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Spinal Cord Stimulation and Small Fiber Peripheral Neuropathy
RECRUITING · NA
-
Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Functional and Neuroprotective Effects of Restoring Lower Limb Sensation After Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Balance Control and Recovery in Diabetes Peripheral Neuropathy
RECRUITING · NA
-
A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.